These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 26748890)

  • 1. Structure-Based Development of an Affinity Probe for Sirtuin 2.
    Schiedel M; Rumpf T; Karaman B; Lehotzky A; Gerhardt S; Ovádi J; Sippl W; Einsle O; Jung M
    Angew Chem Int Ed Engl; 2016 Feb; 55(6):2252-6. PubMed ID: 26748890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aminothiazoles as Potent and Selective Sirt2 Inhibitors: A Structure-Activity Relationship Study.
    Schiedel M; Rumpf T; Karaman B; Lehotzky A; Oláh J; Gerhardt S; Ovádi J; Sippl W; Einsle O; Jung M
    J Med Chem; 2016 Feb; 59(4):1599-612. PubMed ID: 26696402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of the Slow Off-Kinetics of Sirtuin-Rearranging Ligands (SirReals) by Means of Label-Free Electrically Switchable Nanolever Technology.
    Schiedel M; Daub H; Itzen A; Jung M
    Chembiochem; 2020 Apr; 21(8):1161-1166. PubMed ID: 31692222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective Sirt2 inhibition by ligand-induced rearrangement of the active site.
    Rumpf T; Schiedel M; Karaman B; Roessler C; North BJ; Lehotzky A; Oláh J; Ladwein KI; Schmidtkunz K; Gajer M; Pannek M; Steegborn C; Sinclair DA; Gerhardt S; Ovádi J; Schutkowski M; Sippl W; Einsle O; Jung M
    Nat Commun; 2015 Feb; 6():6263. PubMed ID: 25672491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemically Induced Degradation of Sirtuin 2 (Sirt2) by a Proteolysis Targeting Chimera (PROTAC) Based on Sirtuin Rearranging Ligands (SirReals).
    Schiedel M; Herp D; Hammelmann S; Swyter S; Lehotzky A; Robaa D; Oláh J; Ovádi J; Sippl W; Jung M
    J Med Chem; 2018 Jan; 61(2):482-491. PubMed ID: 28379698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New chemical tools for probing activity and inhibition of the NAD
    Swyter S; Schiedel M; Monaldi D; Szunyogh S; Lehotzky A; Rumpf T; Ovádi J; Sippl W; Jung M
    Philos Trans R Soc Lond B Biol Sci; 2018 Jun; 373(1748):. PubMed ID: 29685963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HaloTag-Targeted Sirtuin-Rearranging Ligand (SirReal) for the Development of Proteolysis-Targeting Chimeras (PROTACs) against the Lysine Deacetylase Sirtuin 2 (Sirt2)*.
    Schiedel M; Lehotzky A; Szunyogh S; Oláh J; Hammelmann S; Wössner N; Robaa D; Einsle O; Sippl W; Ovádi J; Jung M
    Chembiochem; 2020 Dec; 21(23):3371-3376. PubMed ID: 32672888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opening the Selectivity Pocket in the Human Lysine Deacetylase Sirtuin2 - New Opportunities, New Questions.
    Robaa D; Monaldi D; Wössner N; Kudo N; Rumpf T; Schiedel M; Yoshida M; Jung M
    Chem Rec; 2018 Dec; 18(12):1701-1707. PubMed ID: 29931800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seeding for sirtuins: microseed matrix seeding to obtain crystals of human Sirt3 and Sirt2 suitable for soaking.
    Rumpf T; Gerhardt S; Einsle O; Jung M
    Acta Crystallogr F Struct Biol Commun; 2015 Dec; 71(Pt 12):1498-510. PubMed ID: 26625292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal structure analysis of human Sirt2 and its ADP-ribose complex.
    Moniot S; Schutkowski M; Steegborn C
    J Struct Biol; 2013 May; 182(2):136-43. PubMed ID: 23454361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Glycoconjugated SIRT2 Inhibitor with Aqueous Solubility Allows Structure-Based Design of SIRT2 Inhibitors.
    Hong JY; Price IR; Bai JJ; Lin H
    ACS Chem Biol; 2019 Aug; 14(8):1802-1810. PubMed ID: 31373792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient demyristoylase activity of SIRT2 revealed by kinetic and structural studies.
    Teng YB; Jing H; Aramsangtienchai P; He B; Khan S; Hu J; Lin H; Hao Q
    Sci Rep; 2015 Feb; 5():8529. PubMed ID: 25704306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular modeling study for conformational changes of Sirtuin 2 due to substrate and inhibitor binding.
    Sakkiah S; Chandrasekaran M; Lee Y; Kim S; Lee KW
    J Biomol Struct Dyn; 2012; 30(3):235-54. PubMed ID: 22694102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity studies on suramin analogues as inhibitors of NAD+-dependent histone deacetylases (sirtuins).
    Trapp J; Meier R; Hongwiset D; Kassack MU; Sippl W; Jung M
    ChemMedChem; 2007 Oct; 2(10):1419-31. PubMed ID: 17628866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deacylation Mechanism by SIRT2 Revealed in the 1'-SH-2'-O-Myristoyl Intermediate Structure.
    Wang Y; Fung YME; Zhang W; He B; Chung MWH; Jin J; Hu J; Lin H; Hao Q
    Cell Chem Biol; 2017 Mar; 24(3):339-345. PubMed ID: 28286128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-activity studies on splitomicin derivatives as sirtuin inhibitors and computational prediction of binding mode.
    Neugebauer RC; Uchiechowska U; Meier R; Hruby H; Valkov V; Verdin E; Sippl W; Jung M
    J Med Chem; 2008 Mar; 51(5):1203-13. PubMed ID: 18269226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Continuous, Fluorogenic Sirtuin 2 Deacylase Assay: Substrate Screening and Inhibitor Evaluation.
    Galleano I; Schiedel M; Jung M; Madsen AS; Olsen CA
    J Med Chem; 2016 Feb; 59(3):1021-31. PubMed ID: 26788965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacophore modeling and virtual screening studies to identify novel selective SIRT2 inhibitors.
    Eren G; Bruno A; Guntekin-Ergun S; Cetin-Atalay R; Ozgencil F; Ozkan Y; Gozelle M; Kaya SG; Costantino G
    J Mol Graph Model; 2019 Jun; 89():60-73. PubMed ID: 30870650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of potent and selective sirtuin 2 (SIRT2) inhibitors using a fragment-based approach.
    Cui H; Kamal Z; Ai T; Xu Y; More SS; Wilson DJ; Chen L
    J Med Chem; 2014 Oct; 57(20):8340-57. PubMed ID: 25275824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thienopyrimidinone Based Sirtuin-2 (SIRT2)-Selective Inhibitors Bind in the Ligand Induced Selectivity Pocket.
    Sundriyal S; Moniot S; Mahmud Z; Yao S; Di Fruscia P; Reynolds CR; Dexter DT; Sternberg MJ; Lam EW; Steegborn C; Fuchter MJ
    J Med Chem; 2017 Mar; 60(5):1928-1945. PubMed ID: 28135086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.